Cannabis biotech company Trait Bio closes $12.3 mln seed deal
Trait Biosciences Inc, a Vancouver-based cannabis biotechnology company, has closed a seed-stage financing of $12.3 million. The round was led by incoming Trait senior managers, Joseph del Moral, Hannan Fleiman and Ronan Levy, and joined by Green Acre Capital, CannaIncome Fund and industry executives. Trait is developing enhanced cannabinoids, including water-soluble cannabinoids. It is also is developing technologies to increase plant yields and safety. The funds raised will be used for research and patent creation, as well as the construction of a second laboratory in Toronto.
25 September 2018•4 mins read
